The DOI matches its Crossref record.
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (the first two years)
Open accessAbstract
The annual incidence of rheumatoid arthritis (RA) in the UK is ∼24 per hundred thousand [1]. The current guideline provides practical evidence-based advice on recommended interventions in RA. The objective is to provide a framework of care for managing RA, including control of synovitis, symptom control, self-management, physical functioning, psychosocial functioning and screening/monitoring. The primary target of this guidance is health professionals and managers; however, it is also relevant to patients with RA. The guidance is limited to the first 2 yrs of RA. This is a short summary of the whole guideline. The full guideline is available on the journal website (see supplementary material for full guideline). The current guideline does not include psoriatic arthritis, disease-modifying anti-rheumatic drugs (DMARDs) or biological therapy in RA because these areas are described in separate British Society for Rheumatology (BSR) guidelines [2–4]. We have produced 24 evidence-based recommendations (using Royal College of Physicians guidelines and the Appraisal of Guidelines Research and Evaluation instrument) [5, 6], each given a grade of recommendation (from A to C), and a flowchart to illustrate the care pathway for patients with RA (Fig. 1). Algorithm for management of early RA. (1) A diagnosis of RA should be made as early as possible, on the basis of persistent joint inflammation affecting at least three joint areas, involvement of the metacarpophalangeal (MCP) or metatarsophalangeal (MTP) joints or early morning stiffness of at least 30 minutes. (C) (2) Patients with suspected early synovitis should have rapid access to a multidisciplinary team including specialists in rheumatology, and members from both primary and secondary care in order to provide a seamless service. (B) (3) Access to individual elements of the multidisciplinary service should be available according to the patient need. (B) (4) Patients with RA should be given a plan of care from diagnosis, including a commitment to training patients to self-manage some aspects of disease. (C) (5) Specialist rheumatology nurses can provide ideal support for patients in accessing elements of the multidisciplinary team and in providing important lifestyle advice. (C) (6) RA is a significant independent risk factor for ischaemic heart disease. Other risk factors for ischaemic heart disease should be sought and treated using primary care services. (B) (7) All patients should have their disease and its impact assessed and documented at onset. Once established on DMARD therapy, patients should have a formal assessment of response to treatment, in order to justify continuing therapy or changing it. Remission should be defined and documented when achieved, in order to plan reduction or maintenance therapy. (B–C) (8) Patients should be established on disease modifying therapy as soon as possible after a diagnosis of RA is made. Therapy should incorporate escalating doses, intra-articular steroid injections, parenteral methotrexate and combination therapy, rather than sequential monotherapy; progression to biologic (anti-TNF-α) therapy should be according to need [4]. (A) (9) Systemic steroids have an important early role in controlling synovitis or bridging disease control between different DMARD therapies but long-term use is not justified. (B) (10) Patients with RA require assessment of pain (A). Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) should be at the lowest effective dose (A). (11) NSAIDs should be avoided in individuals at high risk of cardiovascular morbidity, and used with caution in others who cannot be managed with analgesia, steroid injections and one or more DMARDs. (B) (12) Patients with RA require early assessment of sleep patterns. (A). Early management of sleep disturbance should include tricyclic agents, behavioural therapy and exercise. (B). Consider the impact of fatigue on quality of life in early RA. (B) (13) Evidence for effectiveness of complementary therapy is conflicting. (B) (14) Timing and format (group/individual/written) of education to meet individual needs should be considered. (A). Patients should be offered a cognitive behavioural approach to patient education, delivered at the appropriate time, to promote long-term adherence to management strategies (C). Patients should be helped to contact support organizations such as the National Rheumatoid Arthritis Society (NRAS), Arthritis Care (AC) and the Arthritis Research Campaign (ARC). (B) (15) Patients should be encouraged to pace activities and recognize the limits of physical activity, facilitating a realistic readjustment of expectations. Patients should be helped to participate in exercise programmes. (C) (16) Aerobic exercise should be encouraged to help combat the effects of RA on muscle strength, endurance and aerobic capacity, without, in the short-term, exacerbating disease activity or joint destruction. (B) (17) Hydrotherapy should be accessible
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
BYKERK, V. P., AKHAVAN, P., HAZLEWOOD, G. S., SCHIEIR, O., DOOLEY, A., HARAOUI, B., KHRAISHI, M., LECLERCQ, S. A., LÉGARÉ, J., MOSHER, D. P., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110207 · Cited by 335
Luqmani, R., Hennell, S., Estrach, C., Basher, D., Birrell, F., Bosworth, A., Burke, F., Callaghan, C., Candal-Couto, J., Fokke, C., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/ken450a · Cited by 293
Self-citationDhillon, S. (2010) · Clinical Drug Investigation · doi:10.2165/11205830-000000000-00000 · Cited by 78
Sharpe, L. (2016) · Journal of Pain Research · doi:10.2147/jpr.s83653 · Cited by 64
El Miedany, Y., El Gaafary, M., Youssef, S., Bahlas, S., Almedany, S., Ahmed, I., & Palmer, D. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151421 · Cited by 47
Metadata
- Authors
- Luqmani, R., Hennell, S., Estrach, C., Birrell, F., Bosworth, A., Davenport, G., Fokke, C., Goodson, N., Jeffreson, P., Lamb, E., Mohammed, R., Oliver, S., Stableford, Z., Walsh, D., Washbrook, C., & Webb, F.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-13
- Volume
- 45
- Issue
- 9
- Pages
- 1167-1169
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W4235016009
- Cited by
- 206
- References
- 0
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (the first two years). https://app.cochat.ai/papers/10.1093/rheumatology/kel215a
- The paper
- Luqmani, R., Hennell, S., Estrach, C., Birrell, F., Bosworth, A., Davenport, G., Fokke, C., Goodson, N., Jeffreson, P., Lamb, E., Mohammed, R., Oliver, S., Stableford, Z., Walsh, D., Washbrook, C., & Webb, F. (2006). British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (the first two years). Rheumatology. https://doi.org/10.1093/rheumatology/kel215a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.